SWITCH: An open-label prospective study of switching from pramipexole to ropinirole in RLS

被引：0
|
作者：
Mehta, S. H.
Iyer, S. S.
Bogan, R. K.
Jackson, P. D.
Prakash, R.
Prozonic, J.
Morgan, J. C.
Sethi, K. D.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S443 / S444
页数：2
相关论文
共 50 条
  • [11] A three-arm, open-label conversion study of pramipexole to ropinirole prolonged release tablets in Parkinson's disease patients
    Pahwa, R.
    Lyons, K. E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 126 - 127
  • [12] Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
    Woo, Young Sup
    Yoon, Bo-Hyun
    Jeon, Bong-Hee
    Seo, Jeong Seok
    Nam, Beomwoo
    Lee, Sang-Yeol
    Jae, Young-Myo
    Jang, Sae-Heon
    Eun, Hun Jeong
    Won, Seung-Hee
    Lee, Kwanghun
    Lee, Jonghun
    Bahk, Won-Myong
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2019, 17 (03) : 423 - 431
  • [13] A pilot open-label trial of ropinirole for cocaine dependence
    Meini, Milo
    Capovani, Barbara
    Sbrana, Alfredo
    Massei, Guido Jacopo
    Ravani, Laura
    Massimetti, Gabriele
    Daini, Laura
    Scaramelli, Daniela
    Moncini, Marco
    AMERICAN JOURNAL ON ADDICTIONS, 2008, 17 (02): : 165 - 166
  • [14] Pioglitazone in acromegaly - an open-label, prospective study
    Kim, David D. W.
    Goh, Jovina
    Panossian, Zaven
    Gamble, Greg
    Holdaway, Ian
    Grey, Andrew
    CLINICAL ENDOCRINOLOGY, 2012, 77 (04) : 575 - 578
  • [15] Tolerability of tiagabine: a prospective open-label study
    Bauer, J
    Bergmann, A
    Reuber, M
    Stodieck, SRG
    Genton, P
    EPILEPTIC DISORDERS, 2002, 4 (04) : 257 - 260
  • [16] Efficacy of Switching From Teriparatide to Bisphosphonate or Denosumab: A Prospective, Randomized, Open-Label Trial
    Niimi, Rui
    Kono, Toshibumi
    Nishihara, Atsushi
    Hasegawa, Masahiro
    Kono, Toshihiko
    Sudo, Akihiro
    JBMR PLUS, 2018, 2 (05) : 289 - 294
  • [17] Effectiveness and Tolerability of Switching to Aripiprazole From Risperidone in Subjects With Autism Spectrum Disorders: A Prospective Open-Label Study
    Ishitobi, Makoto
    Kosaka, Hirotaka
    Takahashi, Tetsuya
    Yatuga, Chiho
    Asano, Mizuki
    Tanaka, Yuji
    Ueno, Kanji
    Okazaki, Ryoko
    Omori, Masao
    Hiratani, Michio
    Tomoda, Akemi
    Wada, Yuji
    CLINICAL NEUROPHARMACOLOGY, 2013, 36 (05) : 151 - 156
  • [18] Long-term open-label study to evaluate the safety and efficacy of pramipexole (PPX) in Japanese patients with primary Restless Legs syndrome (RLS)
    Shimiza, T.
    Inoue, Y.
    Kuroda, K.
    Hirata, K.
    Uchimura, N.
    Kagimura, T.
    MOVEMENT DISORDERS, 2009, 24 : S446 - S447
  • [19] Azathioprine in refractory sprue:: Results from a prospective, open-label study
    Mauriño, E
    Niveloni, S
    Cherñavsky, A
    Pedreira, S
    Mazure, R
    Vazquez, H
    Reyes, H
    Fiorini, A
    Smecuol, E
    Cabanne, A
    Capucchio, M
    Kogan, Z
    Bai, JC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (10): : 2595 - 2602
  • [20] Overnight switch from ropinirole, pramipexole, and cabergoline to rotigotine transdermal patch
    LeWitt, P. A.
    Poewe, W.
    Rascol, O.
    Giladi, N.
    Patton, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 321 - 322
12345